A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
Public ClinicalTrials.gov record NCT02102490. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to evaluate whether the study drug known as abemaciclib is effective in treating participants with breast cancer who have already tried other drug treatments.
Study identification
- NCT ID
- NCT02102490
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 132 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 10, 2014 (Actual)
- Primary completion
- Apr 30, 2016 (Actual)
- Completion
- Oct 22, 2018 (Actual)
- Last update posted
- Jan 21, 2020
2014 – 2018
United States locations
- U.S. sites
- 27
- U.S. states
- 13
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northern Arizona Hematology & Oncology Associates | Sedona | Arizona | 86336 | — |
| HOPE Hematology Oncology Physicians and Extenders | Tucson | Arizona | 85704 | — |
| Arizona Clinical Research Center | Tucson | Arizona | 85715 | — |
| Univ of California San Francisco | San Francisco | California | 94115 | — |
| Sansum Medical Research Foundation | Santa Barbara | California | 93105 | — |
| Rocky Mountain Cancer Center | Denver | Colorado | 80220 | — |
| Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| Florida Cancer Specialists | Fort Myers | Florida | 33916 | — |
| Advanced Medical Specialties | Miami | Florida | 33176 | — |
| Florida Cancer Specialists | St. Petersburg | Florida | 33705 | — |
| Maryland Oncology Hematology, P.A. | Columbia | Maryland | 21044 | — |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02115 | — |
| Minnesota Oncology/Hematology PA | Minneapolis | Minnesota | 55404 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| Oncology Hematology Care Inc | Cincinnati | Ohio | 45242 | — |
| Sarah Cannon Research Institute SCRI | Nashville | Tennessee | 37203 | — |
| Texas Oncology Cancer Center | Austin | Texas | 78731 | — |
| Texas Oncology - Bedford | Bedford | Texas | 76022 | — |
| Presbyterian Hospital Dallas | Dallas | Texas | 75231 | — |
| Texas Oncology-Baylor Charles A. Sammons Cancer Center | Dallas | Texas | 75246 | — |
| The Center for Cancer and Blood Disorders | Fort Worth | Texas | 76104 | — |
| Texas Oncology-Memorial City | Houston | Texas | 77024 | — |
| Texas Oncology-Plano West | Plano | Texas | 75093 | — |
| Texas Oncology-Sherman | Sherman | Texas | 75090-0504 | — |
| US Oncology | The Woodlands | Texas | 77380 | — |
| Tyler Cancer Center | Tyler | Texas | 75702 | — |
| Northwest Cancer Specialists PC | Vancouver | Washington | 98684 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02102490, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 21, 2020 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02102490 live on ClinicalTrials.gov.